nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—CYP3A5—Disulfiram—alcohol dependence	0.114	0.222	CbGbCtD
Gefitinib—ABCB1—Naltrexone—alcohol dependence	0.0799	0.155	CbGbCtD
Gefitinib—CYP2C9—Disulfiram—alcohol dependence	0.0766	0.149	CbGbCtD
Gefitinib—CYP2C19—Citalopram—alcohol dependence	0.0656	0.127	CbGbCtD
Gefitinib—ABCB1—Citalopram—alcohol dependence	0.0529	0.103	CbGbCtD
Gefitinib—CYP2D6—Citalopram—alcohol dependence	0.0499	0.0968	CbGbCtD
Gefitinib—CYP3A4—Disulfiram—alcohol dependence	0.0445	0.0864	CbGbCtD
Gefitinib—CYP3A4—Citalopram—alcohol dependence	0.0317	0.0616	CbGbCtD
Gefitinib—Eruption—Disulfiram—alcohol dependence	0.00709	0.035	CcSEcCtD
Gefitinib—ORM1—bile—alcohol dependence	0.00603	0.0395	CbGeAlD
Gefitinib—Necrolysis epidermal—Citalopram—alcohol dependence	0.00567	0.028	CcSEcCtD
Gefitinib—Tenderness—Disulfiram—alcohol dependence	0.005	0.0247	CcSEcCtD
Gefitinib—Oral pain—Citalopram—alcohol dependence	0.00493	0.0244	CcSEcCtD
Gefitinib—Appetite absent—Naltrexone—alcohol dependence	0.00409	0.0202	CcSEcCtD
Gefitinib—ORM1—saliva—alcohol dependence	0.00394	0.0258	CbGeAlD
Gefitinib—Vesiculobullous rash—Acamprosate—alcohol dependence	0.00383	0.0189	CcSEcCtD
Gefitinib—Gastric ulcer—Acamprosate—alcohol dependence	0.0037	0.0183	CcSEcCtD
Gefitinib—Hepatic failure—Disulfiram—alcohol dependence	0.00352	0.0174	CcSEcCtD
Gefitinib—Eye pain—Disulfiram—alcohol dependence	0.00351	0.0173	CcSEcCtD
Gefitinib—Seborrhoeic dermatitis—Naltrexone—alcohol dependence	0.00298	0.0147	CcSEcCtD
Gefitinib—Amblyopia—Acamprosate—alcohol dependence	0.00278	0.0137	CcSEcCtD
Gefitinib—Rash pustular—Acamprosate—alcohol dependence	0.00269	0.0133	CcSEcCtD
Gefitinib—Bundle branch block—Citalopram—alcohol dependence	0.00255	0.0126	CcSEcCtD
Gefitinib—HIPK4—gonad—alcohol dependence	0.00238	0.0156	CbGeAlD
Gefitinib—Gastric ulcer—Citalopram—alcohol dependence	0.00222	0.0109	CcSEcCtD
Gefitinib—Hepatitis—Disulfiram—alcohol dependence	0.00219	0.0108	CcSEcCtD
Gefitinib—Ulcer—Naltrexone—alcohol dependence	0.00215	0.0106	CcSEcCtD
Gefitinib—SBK1—blood—alcohol dependence	0.0021	0.0138	CbGeAlD
Gefitinib—Melaena—Acamprosate—alcohol dependence	0.0021	0.0104	CcSEcCtD
Gefitinib—SBK1—midbrain—alcohol dependence	0.00207	0.0136	CbGeAlD
Gefitinib—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00201	0.00991	CcSEcCtD
Gefitinib—Keratitis—Citalopram—alcohol dependence	0.00199	0.00981	CcSEcCtD
Gefitinib—Mouth ulceration—Acamprosate—alcohol dependence	0.00194	0.0096	CcSEcCtD
Gefitinib—EPHA6—gonad—alcohol dependence	0.00188	0.0123	CbGeAlD
Gefitinib—CHEK2—blood—alcohol dependence	0.00183	0.012	CbGeAlD
Gefitinib—Thrombophlebitis—Acamprosate—alcohol dependence	0.0018	0.0089	CcSEcCtD
Gefitinib—HIPK4—endocrine gland—alcohol dependence	0.0018	0.0118	CbGeAlD
Gefitinib—SBK1—testis—alcohol dependence	0.00174	0.0114	CbGeAlD
Gefitinib—CSNK1E—forebrain—alcohol dependence	0.00173	0.0114	CbGeAlD
Gefitinib—HIPK4—testis—alcohol dependence	0.00172	0.0112	CbGeAlD
Gefitinib—ERBB3—forebrain—alcohol dependence	0.00167	0.011	CbGeAlD
Gefitinib—Amblyopia—Citalopram—alcohol dependence	0.00167	0.00824	CcSEcCtD
Gefitinib—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00165	0.00817	CcSEcCtD
Gefitinib—Dermatitis bullous—Acamprosate—alcohol dependence	0.00163	0.00806	CcSEcCtD
Gefitinib—Rash pustular—Citalopram—alcohol dependence	0.00161	0.00798	CcSEcCtD
Gefitinib—CSNK1E—adrenal cortex—alcohol dependence	0.00161	0.0105	CbGeAlD
Gefitinib—SBK1—cerebellum—alcohol dependence	0.0016	0.0105	CbGeAlD
Gefitinib—IRAK4—adrenal cortex—alcohol dependence	0.00158	0.0104	CbGeAlD
Gefitinib—Atrial fibrillation—Naltrexone—alcohol dependence	0.00156	0.00769	CcSEcCtD
Gefitinib—Acne—Citalopram—alcohol dependence	0.00153	0.00756	CcSEcCtD
Gefitinib—CHEK2—testis—alcohol dependence	0.00151	0.00991	CbGeAlD
Gefitinib—Minaprine—MAOA—alcohol dependence	0.0015	0.155	CrCbGaD
Gefitinib—MKNK2—adrenal cortex—alcohol dependence	0.00147	0.00966	CbGeAlD
Gefitinib—MKNK1—adrenal cortex—alcohol dependence	0.00146	0.00953	CbGeAlD
Gefitinib—Dry skin—Acamprosate—alcohol dependence	0.00143	0.00706	CcSEcCtD
Gefitinib—CSNK1E—pancreas—alcohol dependence	0.00143	0.00933	CbGeAlD
Gefitinib—EPHA6—endocrine gland—alcohol dependence	0.00142	0.00932	CbGeAlD
Gefitinib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.0014	0.00694	CcSEcCtD
Gefitinib—Drug interaction—Citalopram—alcohol dependence	0.00139	0.00686	CcSEcCtD
Gefitinib—ERBB3—pancreas—alcohol dependence	0.00138	0.00901	CbGeAlD
Gefitinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00138	0.0068	CcSEcCtD
Gefitinib—Dehydration—Naltrexone—alcohol dependence	0.00137	0.00678	CcSEcCtD
Gefitinib—EPHA6—testis—alcohol dependence	0.00136	0.00889	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—alcohol dependence	0.00135	0.00881	CbGeAlD
Gefitinib—Fatigue—Disulfiram—alcohol dependence	0.00134	0.00663	CcSEcCtD
Gefitinib—EPHA6—nervous system—alcohol dependence	0.00133	0.00872	CbGeAlD
Gefitinib—Pain—Disulfiram—alcohol dependence	0.00133	0.00657	CcSEcCtD
Gefitinib—MKNK1—cardiovascular system—alcohol dependence	0.00133	0.0087	CbGeAlD
Gefitinib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00133	0.00656	CcSEcCtD
Gefitinib—Pancreatitis—Acamprosate—alcohol dependence	0.00132	0.00653	CcSEcCtD
Gefitinib—MKNK2—pancreas—alcohol dependence	0.00131	0.00856	CbGeAlD
Gefitinib—IRAK1—pancreas—alcohol dependence	0.00131	0.00856	CbGeAlD
Gefitinib—SBK1—brain—alcohol dependence	0.0013	0.00853	CbGeAlD
Gefitinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.0013	0.00643	CcSEcCtD
Gefitinib—HIPK4—brain—alcohol dependence	0.00129	0.00843	CbGeAlD
Gefitinib—EPHA6—central nervous system—alcohol dependence	0.00128	0.0084	CbGeAlD
Gefitinib—Cystitis noninfective—Citalopram—alcohol dependence	0.00126	0.00622	CcSEcCtD
Gefitinib—Melaena—Citalopram—alcohol dependence	0.00126	0.00622	CcSEcCtD
Gefitinib—Cystitis—Citalopram—alcohol dependence	0.00124	0.00614	CcSEcCtD
Gefitinib—MAP3K19—testis—alcohol dependence	0.00123	0.00808	CbGeAlD
Gefitinib—MKNK2—gonad—alcohol dependence	0.00122	0.008	CbGeAlD
Gefitinib—Weight decreased—Acamprosate—alcohol dependence	0.00122	0.00602	CcSEcCtD
Gefitinib—CSNK1E—digestive system—alcohol dependence	0.00122	0.00797	CbGeAlD
Gefitinib—MAP3K19—nervous system—alcohol dependence	0.00121	0.00793	CbGeAlD
Gefitinib—Pneumonia—Acamprosate—alcohol dependence	0.00121	0.00597	CcSEcCtD
Gefitinib—MKNK1—gonad—alcohol dependence	0.00121	0.0079	CbGeAlD
Gefitinib—MAP2K5—brainstem—alcohol dependence	0.0012	0.00784	CbGeAlD
Gefitinib—Dry eye—Citalopram—alcohol dependence	0.00119	0.00588	CcSEcCtD
Gefitinib—Iloperidone—DRD4—alcohol dependence	0.00118	0.121	CrCbGaD
Gefitinib—ERBB3—digestive system—alcohol dependence	0.00117	0.00769	CbGeAlD
Gefitinib—Stomatitis—Acamprosate—alcohol dependence	0.00117	0.00579	CcSEcCtD
Gefitinib—MAP3K19—central nervous system—alcohol dependence	0.00117	0.00763	CbGeAlD
Gefitinib—Bladder pain—Citalopram—alcohol dependence	0.00116	0.00575	CcSEcCtD
Gefitinib—Mouth ulceration—Citalopram—alcohol dependence	0.00116	0.00575	CcSEcCtD
Gefitinib—CSNK1E—blood—alcohol dependence	0.00116	0.00759	CbGeAlD
Gefitinib—Weight decreased—Naltrexone—alcohol dependence	0.00115	0.0057	CcSEcCtD
Gefitinib—Haematuria—Acamprosate—alcohol dependence	0.00115	0.00566	CcSEcCtD
Gefitinib—CSNK1E—midbrain—alcohol dependence	0.00115	0.0075	CbGeAlD
Gefitinib—Pneumonia—Naltrexone—alcohol dependence	0.00114	0.00565	CcSEcCtD
Gefitinib—IRAK4—blood—alcohol dependence	0.00114	0.00748	CbGeAlD
Gefitinib—Infestation NOS—Naltrexone—alcohol dependence	0.00114	0.00562	CcSEcCtD
Gefitinib—Infestation—Naltrexone—alcohol dependence	0.00114	0.00562	CcSEcCtD
Gefitinib—CHEK2—brain—alcohol dependence	0.00114	0.00743	CbGeAlD
Gefitinib—Epistaxis—Acamprosate—alcohol dependence	0.00113	0.0056	CcSEcCtD
Gefitinib—MKNK2—digestive system—alcohol dependence	0.00112	0.00731	CbGeAlD
Gefitinib—Asthenia—Disulfiram—alcohol dependence	0.00112	0.00552	CcSEcCtD
Gefitinib—ERBB3—midbrain—alcohol dependence	0.00111	0.00724	CbGeAlD
Gefitinib—Conjunctivitis—Naltrexone—alcohol dependence	0.00111	0.00546	CcSEcCtD
Gefitinib—MKNK1—digestive system—alcohol dependence	0.0011	0.00722	CbGeAlD
Gefitinib—STK10—cardiovascular system—alcohol dependence	0.00109	0.00716	CbGeAlD
Gefitinib—Haemoglobin—Acamprosate—alcohol dependence	0.00108	0.00536	CcSEcCtD
Gefitinib—Haemorrhage—Acamprosate—alcohol dependence	0.00108	0.00533	CcSEcCtD
Gefitinib—Hepatitis—Acamprosate—alcohol dependence	0.00108	0.00533	CcSEcCtD
Gefitinib—Iloperidone—HTR7—alcohol dependence	0.00108	0.111	CrCbGaD
Gefitinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00108	0.00531	CcSEcCtD
Gefitinib—Epistaxis—Naltrexone—alcohol dependence	0.00107	0.0053	CcSEcCtD
Gefitinib—MAP2K5—adrenal cortex—alcohol dependence	0.00107	0.00701	CbGeAlD
Gefitinib—IRAK1—blood—alcohol dependence	0.00106	0.00697	CbGeAlD
Gefitinib—MKNK2—blood—alcohol dependence	0.00106	0.00697	CbGeAlD
Gefitinib—Oedema peripheral—Acamprosate—alcohol dependence	0.00106	0.00525	CcSEcCtD
Gefitinib—MKNK2—midbrain—alcohol dependence	0.00105	0.00688	CbGeAlD
Gefitinib—IRAK1—midbrain—alcohol dependence	0.00105	0.00688	CbGeAlD
Gefitinib—MKNK1—blood—alcohol dependence	0.00105	0.00688	CbGeAlD
Gefitinib—Hepatic failure—Citalopram—alcohol dependence	0.00104	0.00514	CcSEcCtD
Gefitinib—MKNK1—midbrain—alcohol dependence	0.00104	0.00679	CbGeAlD
Gefitinib—Eye pain—Citalopram—alcohol dependence	0.00104	0.00512	CcSEcCtD
Gefitinib—Hepatitis—Naltrexone—alcohol dependence	0.00102	0.00504	CcSEcCtD
Gefitinib—EPHA6—brain—alcohol dependence	0.00102	0.00667	CbGeAlD
Gefitinib—CSNK1E—endocrine gland—alcohol dependence	0.00101	0.00659	CbGeAlD
Gefitinib—EGFR—testis—alcohol dependence	0.000998	0.00653	CbGeAlD
Gefitinib—STK10—gonad—alcohol dependence	0.000993	0.0065	CbGeAlD
Gefitinib—Atrial fibrillation—Citalopram—alcohol dependence	0.000987	0.00487	CcSEcCtD
Gefitinib—Rash—Disulfiram—alcohol dependence	0.000981	0.00485	CcSEcCtD
Gefitinib—Dermatitis bullous—Citalopram—alcohol dependence	0.000978	0.00483	CcSEcCtD
Gefitinib—MAP2K5—cardiovascular system—alcohol dependence	0.000977	0.0064	CbGeAlD
Gefitinib—ERBB3—endocrine gland—alcohol dependence	0.000971	0.00636	CbGeAlD
Gefitinib—Minaprine—SLC6A4—alcohol dependence	0.000967	0.0997	CrCbGaD
Gefitinib—Minaprine—DRD2—alcohol dependence	0.000962	0.0992	CrCbGaD
Gefitinib—CSNK1E—testis—alcohol dependence	0.00096	0.00628	CbGeAlD
Gefitinib—Eye disorder—Naltrexone—alcohol dependence	0.000954	0.00471	CcSEcCtD
Gefitinib—Alopecia—Acamprosate—alcohol dependence	0.000953	0.00471	CcSEcCtD
Gefitinib—Cardiac disorder—Naltrexone—alcohol dependence	0.000947	0.00468	CcSEcCtD
Gefitinib—IRAK4—testis—alcohol dependence	0.000945	0.00618	CbGeAlD
Gefitinib—EGFR—liver—alcohol dependence	0.000943	0.00618	CbGeAlD
Gefitinib—CSNK1E—nervous system—alcohol dependence	0.000942	0.00617	CbGeAlD
Gefitinib—Malnutrition—Acamprosate—alcohol dependence	0.000939	0.00464	CcSEcCtD
Gefitinib—IRAK4—nervous system—alcohol dependence	0.000927	0.00607	CbGeAlD
Gefitinib—Angiopathy—Naltrexone—alcohol dependence	0.000926	0.00458	CcSEcCtD
Gefitinib—ERBB3—testis—alcohol dependence	0.000926	0.00606	CbGeAlD
Gefitinib—MAP3K19—brain—alcohol dependence	0.000926	0.00606	CbGeAlD
Gefitinib—MKNK2—endocrine gland—alcohol dependence	0.000923	0.00604	CbGeAlD
Gefitinib—EGFR—cerebellum—alcohol dependence	0.000922	0.00603	CbGeAlD
Gefitinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.00092	0.00455	CcSEcCtD
Gefitinib—MKNK1—endocrine gland—alcohol dependence	0.000912	0.00597	CbGeAlD
Gefitinib—ERBB3—nervous system—alcohol dependence	0.000909	0.00595	CbGeAlD
Gefitinib—STK10—digestive system—alcohol dependence	0.000908	0.00595	CbGeAlD
Gefitinib—CSNK1E—liver—alcohol dependence	0.000907	0.00594	CbGeAlD
Gefitinib—CSNK1E—central nervous system—alcohol dependence	0.000907	0.00594	CbGeAlD
Gefitinib—Alopecia—Naltrexone—alcohol dependence	0.000902	0.00446	CcSEcCtD
Gefitinib—IRAK4—liver—alcohol dependence	0.000893	0.00585	CbGeAlD
Gefitinib—IRAK4—central nervous system—alcohol dependence	0.000893	0.00584	CbGeAlD
Gefitinib—Malnutrition—Naltrexone—alcohol dependence	0.000889	0.00439	CcSEcCtD
Gefitinib—CSNK1E—cerebellum—alcohol dependence	0.000886	0.0058	CbGeAlD
Gefitinib—MKNK2—testis—alcohol dependence	0.00088	0.00576	CbGeAlD
Gefitinib—IRAK1—testis—alcohol dependence	0.00088	0.00576	CbGeAlD
Gefitinib—ERBB3—liver—alcohol dependence	0.000875	0.00573	CbGeAlD
Gefitinib—ERBB3—central nervous system—alcohol dependence	0.000875	0.00573	CbGeAlD
Gefitinib—IRAK4—cerebellum—alcohol dependence	0.000872	0.00571	CbGeAlD
Gefitinib—Dehydration—Citalopram—alcohol dependence	0.000869	0.0043	CcSEcCtD
Gefitinib—MKNK1—testis—alcohol dependence	0.000869	0.00569	CbGeAlD
Gefitinib—Anaemia—Acamprosate—alcohol dependence	0.000868	0.00429	CcSEcCtD
Gefitinib—STK10—blood—alcohol dependence	0.000865	0.00567	CbGeAlD
Gefitinib—MKNK2—nervous system—alcohol dependence	0.000864	0.00566	CbGeAlD
Gefitinib—Angioedema—Acamprosate—alcohol dependence	0.000858	0.00424	CcSEcCtD
Gefitinib—Dry skin—Citalopram—alcohol dependence	0.000857	0.00423	CcSEcCtD
Gefitinib—ERBB3—cerebellum—alcohol dependence	0.000855	0.0056	CbGeAlD
Gefitinib—MKNK1—nervous system—alcohol dependence	0.000853	0.00559	CbGeAlD
Gefitinib—Hypokalaemia—Citalopram—alcohol dependence	0.000851	0.0042	CcSEcCtD
Gefitinib—Malaise—Acamprosate—alcohol dependence	0.000847	0.00418	CcSEcCtD
Gefitinib—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.000842	0.00416	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000842	0.00416	CcSEcCtD
Gefitinib—MKNK2—liver—alcohol dependence	0.000832	0.00545	CbGeAlD
Gefitinib—IRAK1—liver—alcohol dependence	0.000832	0.00545	CbGeAlD
Gefitinib—MKNK2—central nervous system—alcohol dependence	0.000832	0.00545	CbGeAlD
Gefitinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000825	0.00407	CcSEcCtD
Gefitinib—MKNK1—liver—alcohol dependence	0.000822	0.00538	CbGeAlD
Gefitinib—MKNK1—central nervous system—alcohol dependence	0.000821	0.00538	CbGeAlD
Gefitinib—Cough—Acamprosate—alcohol dependence	0.00082	0.00405	CcSEcCtD
Gefitinib—MKNK2—cerebellum—alcohol dependence	0.000813	0.00532	CbGeAlD
Gefitinib—IRAK1—cerebellum—alcohol dependence	0.000813	0.00532	CbGeAlD
Gefitinib—Angioedema—Naltrexone—alcohol dependence	0.000812	0.00401	CcSEcCtD
Gefitinib—MKNK1—cerebellum—alcohol dependence	0.000803	0.00526	CbGeAlD
Gefitinib—Malaise—Naltrexone—alcohol dependence	0.000801	0.00396	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000794	0.00392	CcSEcCtD
Gefitinib—Pancreatitis—Citalopram—alcohol dependence	0.000792	0.00391	CcSEcCtD
Gefitinib—Dry mouth—Acamprosate—alcohol dependence	0.000782	0.00386	CcSEcCtD
Gefitinib—Cough—Naltrexone—alcohol dependence	0.000775	0.00383	CcSEcCtD
Gefitinib—MAP2K5—blood—alcohol dependence	0.000773	0.00506	CbGeAlD
Gefitinib—MAP2K5—midbrain—alcohol dependence	0.000763	0.005	CbGeAlD
Gefitinib—Infection—Acamprosate—alcohol dependence	0.000761	0.00376	CcSEcCtD
Gefitinib—Cisapride—DRD2—alcohol dependence	0.00076	0.0784	CrCbGaD
Gefitinib—Shock—Acamprosate—alcohol dependence	0.000754	0.00373	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000751	0.00371	CcSEcCtD
Gefitinib—STK10—endocrine gland—alcohol dependence	0.000751	0.00491	CbGeAlD
Gefitinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.00075	0.00371	CcSEcCtD
Gefitinib—EGFR—brain—alcohol dependence	0.000749	0.0049	CbGeAlD
Gefitinib—Skin disorder—Acamprosate—alcohol dependence	0.000745	0.00368	CcSEcCtD
Gefitinib—Minaprine—HTR2A—alcohol dependence	0.000743	0.0767	CrCbGaD
Gefitinib—Dry mouth—Naltrexone—alcohol dependence	0.00074	0.00366	CcSEcCtD
Gefitinib—Weight decreased—Citalopram—alcohol dependence	0.000731	0.00361	CcSEcCtD
Gefitinib—Anorexia—Acamprosate—alcohol dependence	0.000731	0.00361	CcSEcCtD
Gefitinib—Pneumonia—Citalopram—alcohol dependence	0.000725	0.00358	CcSEcCtD
Gefitinib—Infection—Naltrexone—alcohol dependence	0.00072	0.00356	CcSEcCtD
Gefitinib—Infestation NOS—Citalopram—alcohol dependence	0.00072	0.00356	CcSEcCtD
Gefitinib—Infestation—Citalopram—alcohol dependence	0.00072	0.00356	CcSEcCtD
Gefitinib—CSNK1E—brain—alcohol dependence	0.00072	0.00471	CbGeAlD
Gefitinib—Hypotension—Acamprosate—alcohol dependence	0.000716	0.00354	CcSEcCtD
Gefitinib—STK10—testis—alcohol dependence	0.000716	0.00469	CbGeAlD
Gefitinib—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000714	0.00353	CcSEcCtD
Gefitinib—Shock—Naltrexone—alcohol dependence	0.000713	0.00353	CcSEcCtD
Gefitinib—Nervous system disorder—Naltrexone—alcohol dependence	0.000711	0.00351	CcSEcCtD
Gefitinib—IRAK4—brain—alcohol dependence	0.000709	0.00464	CbGeAlD
Gefitinib—Skin disorder—Naltrexone—alcohol dependence	0.000704	0.00348	CcSEcCtD
Gefitinib—STK10—nervous system—alcohol dependence	0.000703	0.0046	CbGeAlD
Gefitinib—Stomatitis—Citalopram—alcohol dependence	0.000702	0.00347	CcSEcCtD
Gefitinib—Iloperidone—DRD2—alcohol dependence	0.000702	0.0724	CrCbGaD
Gefitinib—Conjunctivitis—Citalopram—alcohol dependence	0.0007	0.00346	CcSEcCtD
Gefitinib—ERBB3—brain—alcohol dependence	0.000695	0.00455	CbGeAlD
Gefitinib—Anorexia—Naltrexone—alcohol dependence	0.000691	0.00342	CcSEcCtD
Gefitinib—Haematuria—Citalopram—alcohol dependence	0.000687	0.00339	CcSEcCtD
Gefitinib—Dyspnoea—Acamprosate—alcohol dependence	0.000683	0.00338	CcSEcCtD
Gefitinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000681	0.00337	CcSEcCtD
Gefitinib—Epistaxis—Citalopram—alcohol dependence	0.00068	0.00336	CcSEcCtD
Gefitinib—STK10—liver—alcohol dependence	0.000677	0.00443	CbGeAlD
Gefitinib—STK10—central nervous system—alcohol dependence	0.000676	0.00443	CbGeAlD
Gefitinib—Iloperidone—CYP2E1—alcohol dependence	0.000675	0.0697	CrCbGaD
Gefitinib—MAP2K5—endocrine gland—alcohol dependence	0.00067	0.00439	CbGeAlD
Gefitinib—Decreased appetite—Acamprosate—alcohol dependence	0.000666	0.00329	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000662	0.00327	CcSEcCtD
Gefitinib—STK10—cerebellum—alcohol dependence	0.000661	0.00433	CbGeAlD
Gefitinib—MKNK2—brain—alcohol dependence	0.00066	0.00432	CbGeAlD
Gefitinib—IRAK1—brain—alcohol dependence	0.00066	0.00432	CbGeAlD
Gefitinib—Pain—Acamprosate—alcohol dependence	0.000655	0.00324	CcSEcCtD
Gefitinib—Constipation—Acamprosate—alcohol dependence	0.000655	0.00324	CcSEcCtD
Gefitinib—MKNK1—brain—alcohol dependence	0.000652	0.00427	CbGeAlD
Gefitinib—Haemoglobin—Citalopram—alcohol dependence	0.00065	0.00321	CcSEcCtD
Gefitinib—Haemorrhage—Citalopram—alcohol dependence	0.000647	0.0032	CcSEcCtD
Gefitinib—Hepatitis—Citalopram—alcohol dependence	0.000647	0.0032	CcSEcCtD
Gefitinib—Dyspnoea—Naltrexone—alcohol dependence	0.000647	0.00319	CcSEcCtD
Gefitinib—MAP2K5—testis—alcohol dependence	0.000639	0.00419	CbGeAlD
Gefitinib—Urinary tract disorder—Citalopram—alcohol dependence	0.000639	0.00316	CcSEcCtD
Gefitinib—Oedema peripheral—Citalopram—alcohol dependence	0.000637	0.00315	CcSEcCtD
Gefitinib—Urethral disorder—Citalopram—alcohol dependence	0.000634	0.00313	CcSEcCtD
Gefitinib—Decreased appetite—Naltrexone—alcohol dependence	0.00063	0.00311	CcSEcCtD
Gefitinib—ORM1—blood—alcohol dependence	0.000627	0.00411	CbGeAlD
Gefitinib—MAP2K5—nervous system—alcohol dependence	0.000627	0.00411	CbGeAlD
Gefitinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000627	0.0031	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000626	0.00309	CcSEcCtD
Gefitinib—Fatigue—Naltrexone—alcohol dependence	0.000625	0.00309	CcSEcCtD
Gefitinib—Constipation—Naltrexone—alcohol dependence	0.00062	0.00306	CcSEcCtD
Gefitinib—Pain—Naltrexone—alcohol dependence	0.00062	0.00306	CcSEcCtD
Gefitinib—Erythema multiforme—Citalopram—alcohol dependence	0.000612	0.00302	CcSEcCtD
Gefitinib—Urticaria—Acamprosate—alcohol dependence	0.000609	0.00301	CcSEcCtD
Gefitinib—Body temperature increased—Acamprosate—alcohol dependence	0.000606	0.00299	CcSEcCtD
Gefitinib—Abdominal pain—Acamprosate—alcohol dependence	0.000606	0.00299	CcSEcCtD
Gefitinib—Eye disorder—Citalopram—alcohol dependence	0.000604	0.00299	CcSEcCtD
Gefitinib—MAP2K5—liver—alcohol dependence	0.000604	0.00396	CbGeAlD
Gefitinib—MAP2K5—central nervous system—alcohol dependence	0.000604	0.00395	CbGeAlD
Gefitinib—Cardiac disorder—Citalopram—alcohol dependence	0.0006	0.00297	CcSEcCtD
Gefitinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000593	0.00293	CcSEcCtD
Gefitinib—MAP2K5—cerebellum—alcohol dependence	0.00059	0.00387	CbGeAlD
Gefitinib—Cisapride—HTR2A—alcohol dependence	0.000588	0.0606	CrCbGaD
Gefitinib—Angiopathy—Citalopram—alcohol dependence	0.000587	0.0029	CcSEcCtD
Gefitinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000583	0.00288	CcSEcCtD
Gefitinib—Arrhythmia—Citalopram—alcohol dependence	0.000578	0.00285	CcSEcCtD
Gefitinib—Urticaria—Naltrexone—alcohol dependence	0.000576	0.00285	CcSEcCtD
Gefitinib—Abdominal pain—Naltrexone—alcohol dependence	0.000573	0.00283	CcSEcCtD
Gefitinib—Body temperature increased—Naltrexone—alcohol dependence	0.000573	0.00283	CcSEcCtD
Gefitinib—Alopecia—Citalopram—alcohol dependence	0.000572	0.00282	CcSEcCtD
Gefitinib—Hypersensitivity—Acamprosate—alcohol dependence	0.000565	0.00279	CcSEcCtD
Gefitinib—Malnutrition—Citalopram—alcohol dependence	0.000563	0.00278	CcSEcCtD
Gefitinib—Asthenia—Acamprosate—alcohol dependence	0.00055	0.00272	CcSEcCtD
Gefitinib—ORM1—endocrine gland—alcohol dependence	0.000544	0.00356	CbGeAlD
Gefitinib—Pruritus—Acamprosate—alcohol dependence	0.000542	0.00268	CcSEcCtD
Gefitinib—Iloperidone—HTR2A—alcohol dependence	0.000542	0.0559	CrCbGaD
Gefitinib—STK10—brain—alcohol dependence	0.000537	0.00352	CbGeAlD
Gefitinib—Hypersensitivity—Naltrexone—alcohol dependence	0.000534	0.00264	CcSEcCtD
Gefitinib—Diarrhoea—Acamprosate—alcohol dependence	0.000524	0.00259	CcSEcCtD
Gefitinib—ABCG2—adrenal cortex—alcohol dependence	0.000521	0.00341	CbGeAlD
Gefitinib—Anaemia—Citalopram—alcohol dependence	0.00052	0.00257	CcSEcCtD
Gefitinib—Asthenia—Naltrexone—alcohol dependence	0.00052	0.00257	CcSEcCtD
Gefitinib—Angioedema—Citalopram—alcohol dependence	0.000514	0.00254	CcSEcCtD
Gefitinib—Pruritus—Naltrexone—alcohol dependence	0.000513	0.00253	CcSEcCtD
Gefitinib—ORM1—nervous system—alcohol dependence	0.000509	0.00334	CbGeAlD
Gefitinib—Malaise—Citalopram—alcohol dependence	0.000508	0.00251	CcSEcCtD
Gefitinib—Diarrhoea—Naltrexone—alcohol dependence	0.000496	0.00245	CcSEcCtD
Gefitinib—Cough—Citalopram—alcohol dependence	0.000491	0.00243	CcSEcCtD
Gefitinib—ORM1—liver—alcohol dependence	0.000491	0.00321	CbGeAlD
Gefitinib—ORM1—central nervous system—alcohol dependence	0.00049	0.00321	CbGeAlD
Gefitinib—Vomiting—Acamprosate—alcohol dependence	0.000487	0.00241	CcSEcCtD
Gefitinib—Rash—Acamprosate—alcohol dependence	0.000483	0.00239	CcSEcCtD
Gefitinib—Dermatitis—Acamprosate—alcohol dependence	0.000483	0.00239	CcSEcCtD
Gefitinib—MAP2K5—brain—alcohol dependence	0.00048	0.00314	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000476	0.00235	CcSEcCtD
Gefitinib—Dry mouth—Citalopram—alcohol dependence	0.000469	0.00232	CcSEcCtD
Gefitinib—CYP2C19—digestive system—alcohol dependence	0.000465	0.00304	CbGeAlD
Gefitinib—Vomiting—Naltrexone—alcohol dependence	0.000461	0.00228	CcSEcCtD
Gefitinib—Rash—Naltrexone—alcohol dependence	0.000457	0.00226	CcSEcCtD
Gefitinib—Dermatitis—Naltrexone—alcohol dependence	0.000457	0.00226	CcSEcCtD
Gefitinib—Infection—Citalopram—alcohol dependence	0.000456	0.00226	CcSEcCtD
Gefitinib—Nausea—Acamprosate—alcohol dependence	0.000455	0.00225	CcSEcCtD
Gefitinib—ALB—testis—alcohol dependence	0.000455	0.00298	CbGeAlD
Gefitinib—Shock—Citalopram—alcohol dependence	0.000452	0.00223	CcSEcCtD
Gefitinib—Nervous system disorder—Citalopram—alcohol dependence	0.000451	0.00223	CcSEcCtD
Gefitinib—Thrombocytopenia—Citalopram—alcohol dependence	0.00045	0.00222	CcSEcCtD
Gefitinib—Skin disorder—Citalopram—alcohol dependence	0.000446	0.00221	CcSEcCtD
Gefitinib—CYP2C19—blood—alcohol dependence	0.000443	0.0029	CbGeAlD
Gefitinib—Anorexia—Citalopram—alcohol dependence	0.000438	0.00216	CcSEcCtD
Gefitinib—CYP2C9—cardiovascular system—alcohol dependence	0.000434	0.00284	CbGeAlD
Gefitinib—Nausea—Naltrexone—alcohol dependence	0.000431	0.00213	CcSEcCtD
Gefitinib—ALB—liver—alcohol dependence	0.00043	0.00282	CbGeAlD
Gefitinib—Hypotension—Citalopram—alcohol dependence	0.000429	0.00212	CcSEcCtD
Gefitinib—CYP3A5—pancreas—alcohol dependence	0.000429	0.00281	CbGeAlD
Gefitinib—Dyspnoea—Citalopram—alcohol dependence	0.00041	0.00202	CcSEcCtD
Gefitinib—Decreased appetite—Citalopram—alcohol dependence	0.000399	0.00197	CcSEcCtD
Gefitinib—CYP2D6—brainstem—alcohol dependence	0.000399	0.00261	CbGeAlD
Gefitinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000397	0.00196	CcSEcCtD
Gefitinib—Fatigue—Citalopram—alcohol dependence	0.000396	0.00196	CcSEcCtD
Gefitinib—Constipation—Citalopram—alcohol dependence	0.000393	0.00194	CcSEcCtD
Gefitinib—Pain—Citalopram—alcohol dependence	0.000393	0.00194	CcSEcCtD
Gefitinib—CYP2D6—forebrain—alcohol dependence	0.000385	0.00252	CbGeAlD
Gefitinib—CYP2C19—endocrine gland—alcohol dependence	0.000384	0.00252	CbGeAlD
Gefitinib—ABCG2—blood—alcohol dependence	0.000376	0.00246	CbGeAlD
Gefitinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000376	0.00186	CcSEcCtD
Gefitinib—CYP1A1—digestive system—alcohol dependence	0.000375	0.00245	CbGeAlD
Gefitinib—ABCG2—midbrain—alcohol dependence	0.000371	0.00243	CbGeAlD
Gefitinib—CYP3A5—digestive system—alcohol dependence	0.000366	0.0024	CbGeAlD
Gefitinib—Urticaria—Citalopram—alcohol dependence	0.000365	0.0018	CcSEcCtD
Gefitinib—Abdominal pain—Citalopram—alcohol dependence	0.000363	0.00179	CcSEcCtD
Gefitinib—Body temperature increased—Citalopram—alcohol dependence	0.000363	0.00179	CcSEcCtD
Gefitinib—CYP2C9—digestive system—alcohol dependence	0.000361	0.00236	CbGeAlD
Gefitinib—CYP1A1—blood—alcohol dependence	0.000357	0.00234	CbGeAlD
Gefitinib—CYP3A5—blood—alcohol dependence	0.000349	0.00229	CbGeAlD
Gefitinib—CYP2C19—liver—alcohol dependence	0.000346	0.00227	CbGeAlD
Gefitinib—CYP2C9—blood—alcohol dependence	0.000343	0.00225	CbGeAlD
Gefitinib—ALB—brain—alcohol dependence	0.000341	0.00224	CbGeAlD
Gefitinib—Hypersensitivity—Citalopram—alcohol dependence	0.000339	0.00167	CcSEcCtD
Gefitinib—Asthenia—Citalopram—alcohol dependence	0.00033	0.00163	CcSEcCtD
Gefitinib—Pruritus—Citalopram—alcohol dependence	0.000325	0.00161	CcSEcCtD
Gefitinib—Diarrhoea—Citalopram—alcohol dependence	0.000314	0.00155	CcSEcCtD
Gefitinib—ABCG2—testis—alcohol dependence	0.000311	0.00204	CbGeAlD
Gefitinib—CYP1A1—endocrine gland—alcohol dependence	0.00031	0.00203	CbGeAlD
Gefitinib—CYP3A5—endocrine gland—alcohol dependence	0.000303	0.00198	CbGeAlD
Gefitinib—CYP2C9—endocrine gland—alcohol dependence	0.000298	0.00195	CbGeAlD
Gefitinib—ABCG2—liver—alcohol dependence	0.000294	0.00192	CbGeAlD
Gefitinib—Vomiting—Citalopram—alcohol dependence	0.000292	0.00144	CcSEcCtD
Gefitinib—CYP1A1—nervous system—alcohol dependence	0.00029	0.0019	CbGeAlD
Gefitinib—Rash—Citalopram—alcohol dependence	0.00029	0.00143	CcSEcCtD
Gefitinib—Dermatitis—Citalopram—alcohol dependence	0.000289	0.00143	CcSEcCtD
Gefitinib—ABCG2—cerebellum—alcohol dependence	0.000287	0.00188	CbGeAlD
Gefitinib—CYP1A1—liver—alcohol dependence	0.000279	0.00183	CbGeAlD
Gefitinib—CYP1A1—central nervous system—alcohol dependence	0.000279	0.00183	CbGeAlD
Gefitinib—ABCB1—forebrain—alcohol dependence	0.000277	0.00182	CbGeAlD
Gefitinib—CYP3A4—digestive system—alcohol dependence	0.000275	0.0018	CbGeAlD
Gefitinib—Nausea—Citalopram—alcohol dependence	0.000273	0.00135	CcSEcCtD
Gefitinib—CYP3A5—liver—alcohol dependence	0.000273	0.00179	CbGeAlD
Gefitinib—CYP2D6—digestive system—alcohol dependence	0.000271	0.00177	CbGeAlD
Gefitinib—CYP2C9—liver—alcohol dependence	0.000269	0.00176	CbGeAlD
Gefitinib—CYP3A4—blood—alcohol dependence	0.000262	0.00171	CbGeAlD
Gefitinib—CYP2D6—blood—alcohol dependence	0.000258	0.00169	CbGeAlD
Gefitinib—ABCB1—adrenal cortex—alcohol dependence	0.000257	0.00168	CbGeAlD
Gefitinib—ABCB1—cardiovascular system—alcohol dependence	0.000234	0.00153	CbGeAlD
Gefitinib—ABCG2—brain—alcohol dependence	0.000233	0.00153	CbGeAlD
Gefitinib—ABCB1—pancreas—alcohol dependence	0.000228	0.00149	CbGeAlD
Gefitinib—CYP3A4—endocrine gland—alcohol dependence	0.000227	0.00149	CbGeAlD
Gefitinib—CYP2D6—endocrine gland—alcohol dependence	0.000224	0.00146	CbGeAlD
Gefitinib—CYP1A1—brain—alcohol dependence	0.000221	0.00145	CbGeAlD
Gefitinib—CYP2D6—testis—alcohol dependence	0.000213	0.0014	CbGeAlD
Gefitinib—ABCB1—gonad—alcohol dependence	0.000213	0.00139	CbGeAlD
Gefitinib—CYP3A4—nervous system—alcohol dependence	0.000213	0.00139	CbGeAlD
Gefitinib—CYP2D6—nervous system—alcohol dependence	0.000209	0.00137	CbGeAlD
Gefitinib—CYP3A4—liver—alcohol dependence	0.000205	0.00134	CbGeAlD
Gefitinib—CYP3A4—central nervous system—alcohol dependence	0.000205	0.00134	CbGeAlD
Gefitinib—CYP2D6—liver—alcohol dependence	0.000202	0.00132	CbGeAlD
Gefitinib—CYP2D6—central nervous system—alcohol dependence	0.000201	0.00132	CbGeAlD
Gefitinib—CYP2D6—cerebellum—alcohol dependence	0.000197	0.00129	CbGeAlD
Gefitinib—ABCB1—digestive system—alcohol dependence	0.000195	0.00127	CbGeAlD
Gefitinib—ABCB1—blood—alcohol dependence	0.000185	0.00121	CbGeAlD
Gefitinib—ABCB1—midbrain—alcohol dependence	0.000183	0.0012	CbGeAlD
Gefitinib—ABCB1—endocrine gland—alcohol dependence	0.000161	0.00105	CbGeAlD
Gefitinib—CYP2D6—brain—alcohol dependence	0.00016	0.00105	CbGeAlD
Gefitinib—ABCB1—testis—alcohol dependence	0.000153	0.001	CbGeAlD
Gefitinib—ABCB1—nervous system—alcohol dependence	0.000151	0.000985	CbGeAlD
Gefitinib—ABCB1—liver—alcohol dependence	0.000145	0.000949	CbGeAlD
Gefitinib—ABCB1—central nervous system—alcohol dependence	0.000145	0.000949	CbGeAlD
Gefitinib—ABCB1—cerebellum—alcohol dependence	0.000142	0.000927	CbGeAlD
Gefitinib—ABCB1—brain—alcohol dependence	0.000115	0.000753	CbGeAlD
Gefitinib—MAP2K5—Signaling Pathways—NPY—alcohol dependence	5.39e-05	0.00045	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADH7—alcohol dependence	5.37e-05	0.000448	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—DRD2—alcohol dependence	5.36e-05	0.000447	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR7—alcohol dependence	5.36e-05	0.000447	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—EP300—alcohol dependence	5.33e-05	0.000445	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—OPRM1—alcohol dependence	5.32e-05	0.000444	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADH1A—alcohol dependence	5.32e-05	0.000444	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	5.27e-05	0.00044	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—WASF1—alcohol dependence	5.22e-05	0.000436	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	5.22e-05	0.000436	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.21e-05	0.000435	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CRH—alcohol dependence	5.2e-05	0.000434	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR1B—alcohol dependence	5.2e-05	0.000434	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NPY—alcohol dependence	5.2e-05	0.000434	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	5.16e-05	0.000431	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GGT2—alcohol dependence	5.14e-05	0.00043	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CHRM2—alcohol dependence	5.12e-05	0.000428	CbGpPWpGaD
Gefitinib—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	5.09e-05	0.000425	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—EP300—alcohol dependence	5.05e-05	0.000421	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADH1A—alcohol dependence	5.02e-05	0.00042	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CRH—alcohol dependence	5.01e-05	0.000419	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR1B—alcohol dependence	5.01e-05	0.000419	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADH6—alcohol dependence	4.96e-05	0.000414	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—NPY—alcohol dependence	4.9e-05	0.000409	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADH6—alcohol dependence	4.84e-05	0.000404	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2A—alcohol dependence	4.83e-05	0.000403	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—GGT1—alcohol dependence	4.74e-05	0.000396	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR1B—alcohol dependence	4.73e-05	0.000395	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CRH—alcohol dependence	4.73e-05	0.000395	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADH1B—alcohol dependence	4.71e-05	0.000393	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—OPRM1—alcohol dependence	4.7e-05	0.000393	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—POMC—alcohol dependence	4.6e-05	0.000384	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADH1A—alcohol dependence	4.58e-05	0.000382	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADH6—alcohol dependence	4.56e-05	0.000381	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—AVP—alcohol dependence	4.56e-05	0.000381	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD4—alcohol dependence	4.55e-05	0.00038	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADH6—alcohol dependence	4.52e-05	0.000378	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADH4—alcohol dependence	4.52e-05	0.000378	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AVP—alcohol dependence	4.51e-05	0.000377	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD4—alcohol dependence	4.38e-05	0.000366	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CNR1—alcohol dependence	4.34e-05	0.000363	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NPY—alcohol dependence	4.33e-05	0.000361	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADH4—alcohol dependence	4.27e-05	0.000357	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—MAOA—alcohol dependence	4.25e-05	0.000355	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR7—alcohol dependence	4.24e-05	0.000354	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD2—alcohol dependence	4.24e-05	0.000354	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—POMC—alcohol dependence	4.23e-05	0.000353	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—POMC—alcohol dependence	4.19e-05	0.00035	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CNR1—alcohol dependence	4.19e-05	0.000349	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CRH—alcohol dependence	4.18e-05	0.000349	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR1B—alcohol dependence	4.18e-05	0.000349	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD4—alcohol dependence	4.13e-05	0.000345	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADH1A—alcohol dependence	4.11e-05	0.000343	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—OPRD1—alcohol dependence	4.09e-05	0.000341	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD2—alcohol dependence	4.08e-05	0.000341	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR7—alcohol dependence	4.08e-05	0.000341	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—EP300—alcohol dependence	4.02e-05	0.000336	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADH1A—alcohol dependence	4.01e-05	0.000335	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CNR1—alcohol dependence	3.94e-05	0.000329	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PDYN—alcohol dependence	3.92e-05	0.000327	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MAOB—alcohol dependence	3.9e-05	0.000326	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADH4—alcohol dependence	3.89e-05	0.000325	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—POMC—alcohol dependence	3.85e-05	0.000322	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD2—alcohol dependence	3.85e-05	0.000321	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR7—alcohol dependence	3.85e-05	0.000321	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADH7—alcohol dependence	3.84e-05	0.000321	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADH1A—alcohol dependence	3.78e-05	0.000316	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2A—alcohol dependence	3.75e-05	0.000313	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADH1A—alcohol dependence	3.75e-05	0.000313	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.7e-05	0.000309	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GGT2—alcohol dependence	3.69e-05	0.000308	CbGpPWpGaD
Gefitinib—MKNK1—Disease—EP300—alcohol dependence	3.65e-05	0.000305	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD4—alcohol dependence	3.65e-05	0.000305	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—WASF2—alcohol dependence	3.64e-05	0.000304	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CRHR1—alcohol dependence	3.64e-05	0.000304	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADH7—alcohol dependence	3.63e-05	0.000303	CbGpPWpGaD
Gefitinib—EGFR—Disease—GOT2—alcohol dependence	3.61e-05	0.000301	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	3.59e-05	0.0003	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AVP—alcohol dependence	3.57e-05	0.000298	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADH4—alcohol dependence	3.5e-05	0.000292	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—WASF1—alcohol dependence	3.49e-05	0.000292	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CNR1—alcohol dependence	3.48e-05	0.000291	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT2—alcohol dependence	3.48e-05	0.000291	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AVP—alcohol dependence	3.44e-05	0.000287	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CHRM2—alcohol dependence	3.42e-05	0.000286	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADH4—alcohol dependence	3.41e-05	0.000285	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	3.4e-05	0.000284	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR7—alcohol dependence	3.4e-05	0.000284	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD2—alcohol dependence	3.4e-05	0.000284	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.37e-05	0.000282	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADH1B—alcohol dependence	3.37e-05	0.000282	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—EP300—alcohol dependence	3.35e-05	0.00028	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALDH2—alcohol dependence	3.32e-05	0.000277	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADH7—alcohol dependence	3.31e-05	0.000276	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AVP—alcohol dependence	3.24e-05	0.00027	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADH4—alcohol dependence	3.22e-05	0.000268	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADH4—alcohol dependence	3.19e-05	0.000266	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADH1B—alcohol dependence	3.19e-05	0.000266	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT2—alcohol dependence	3.17e-05	0.000265	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—OPRM1—alcohol dependence	3.14e-05	0.000263	CbGpPWpGaD
Gefitinib—EGFR—Disease—GOT1—alcohol dependence	3.11e-05	0.00026	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	3.03e-05	0.000253	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—POMC—alcohol dependence	3e-05	0.00025	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH6—alcohol dependence	2.98e-05	0.000249	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.98e-05	0.000249	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADH7—alcohol dependence	2.97e-05	0.000248	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2A—alcohol dependence	2.97e-05	0.000248	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—EP300—alcohol dependence	2.94e-05	0.000245	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADH1B—alcohol dependence	2.9e-05	0.000242	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADH7—alcohol dependence	2.9e-05	0.000242	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NPY—alcohol dependence	2.89e-05	0.000242	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AVP—alcohol dependence	2.86e-05	0.000239	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2A—alcohol dependence	2.86e-05	0.000239	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT2—alcohol dependence	2.85e-05	0.000238	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—EP300—alcohol dependence	2.84e-05	0.000237	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GOT2—alcohol dependence	2.82e-05	0.000235	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	2.81e-05	0.000235	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MAOB—alcohol dependence	2.79e-05	0.000233	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1B—alcohol dependence	2.79e-05	0.000233	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CRH—alcohol dependence	2.79e-05	0.000233	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT2—alcohol dependence	2.78e-05	0.000232	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.77e-05	0.000231	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.76e-05	0.00023	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.74e-05	0.000229	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADH7—alcohol dependence	2.73e-05	0.000228	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADH7—alcohol dependence	2.71e-05	0.000226	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2A—alcohol dependence	2.7e-05	0.000225	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CYP2E1—alcohol dependence	2.65e-05	0.000221	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MAOB—alcohol dependence	2.64e-05	0.00022	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT2—alcohol dependence	2.62e-05	0.000219	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADH1B—alcohol dependence	2.61e-05	0.000218	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT2—alcohol dependence	2.6e-05	0.000217	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EP300—alcohol dependence	2.56e-05	0.000214	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADH1B—alcohol dependence	2.54e-05	0.000212	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—EP300—alcohol dependence	2.54e-05	0.000212	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	2.47e-05	0.000206	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	2.47e-05	0.000206	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD4—alcohol dependence	2.44e-05	0.000204	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GGT1—alcohol dependence	2.43e-05	0.000203	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GOT1—alcohol dependence	2.43e-05	0.000203	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MAOB—alcohol dependence	2.41e-05	0.000201	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADH1B—alcohol dependence	2.4e-05	0.0002	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2A—alcohol dependence	2.38e-05	0.000199	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADH1B—alcohol dependence	2.38e-05	0.000198	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALDH2—alcohol dependence	2.38e-05	0.000198	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—POMC—alcohol dependence	2.37e-05	0.000198	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—EP300—alcohol dependence	2.34e-05	0.000196	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CNR1—alcohol dependence	2.33e-05	0.000195	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—alcohol dependence	2.28e-05	0.000191	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR7—alcohol dependence	2.27e-05	0.00019	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD2—alcohol dependence	2.27e-05	0.00019	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALDH2—alcohol dependence	2.24e-05	0.000187	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—EP300—alcohol dependence	2.24e-05	0.000187	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MAOA—alcohol dependence	2.18e-05	0.000182	CbGpPWpGaD
Gefitinib—ERBB3—Disease—EP300—alcohol dependence	2.16e-05	0.000181	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MAOB—alcohol dependence	2.16e-05	0.00018	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	2.16e-05	0.00018	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—alcohol dependence	2.15e-05	0.00018	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MAOB—alcohol dependence	2.11e-05	0.000176	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH4—alcohol dependence	2.1e-05	0.000176	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ALDH2—alcohol dependence	2.05e-05	0.000171	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GOT2—alcohol dependence	2.02e-05	0.000169	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EP300—alcohol dependence	1.99e-05	0.000166	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MAOB—alcohol dependence	1.99e-05	0.000166	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOB—alcohol dependence	1.97e-05	0.000164	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.97e-05	0.000164	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—EP300—alcohol dependence	1.95e-05	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AVP—alcohol dependence	1.91e-05	0.00016	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT2—alcohol dependence	1.91e-05	0.000159	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—alcohol dependence	1.9e-05	0.000159	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CYP2E1—alcohol dependence	1.9e-05	0.000159	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALDH2—alcohol dependence	1.84e-05	0.000153	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CYP2E1—alcohol dependence	1.79e-05	0.00015	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.79e-05	0.00015	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.79e-05	0.000149	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.77e-05	0.000147	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GGT1—alcohol dependence	1.74e-05	0.000146	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GOT1—alcohol dependence	1.74e-05	0.000146	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT2—alcohol dependence	1.74e-05	0.000145	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.71e-05	0.000143	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.69e-05	0.000141	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALDH2—alcohol dependence	1.67e-05	0.00014	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT1—alcohol dependence	1.65e-05	0.000138	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT1—alcohol dependence	1.65e-05	0.000138	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CYP2E1—alcohol dependence	1.64e-05	0.000137	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.61e-05	0.000134	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—alcohol dependence	1.59e-05	0.000133	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EP300—alcohol dependence	1.57e-05	0.000131	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.57e-05	0.000131	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MAOA—alcohol dependence	1.56e-05	0.00013	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT2—alcohol dependence	1.56e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT2—alcohol dependence	1.52e-05	0.000127	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EP300—alcohol dependence	1.52e-05	0.000127	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT1—alcohol dependence	1.5e-05	0.000125	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT1—alcohol dependence	1.5e-05	0.000125	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MAOA—alcohol dependence	1.48e-05	0.000123	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CYP2E1—alcohol dependence	1.47e-05	0.000123	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT2—alcohol dependence	1.44e-05	0.00012	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—EP300—alcohol dependence	1.43e-05	0.00012	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.43e-05	0.00012	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.43e-05	0.00012	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT2—alcohol dependence	1.42e-05	0.000119	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—alcohol dependence	1.42e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.35e-05	0.000113	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT1—alcohol dependence	1.35e-05	0.000113	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT1—alcohol dependence	1.35e-05	0.000113	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MAOA—alcohol dependence	1.35e-05	0.000112	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CYP2E1—alcohol dependence	1.34e-05	0.000112	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT1—alcohol dependence	1.32e-05	0.00011	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT1—alcohol dependence	1.32e-05	0.00011	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.3e-05	0.000109	CbGpPWpGaD
Gefitinib—EGFR—Immune System—EP300—alcohol dependence	1.3e-05	0.000109	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOB—alcohol dependence	1.3e-05	0.000108	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—alcohol dependence	1.27e-05	0.000106	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EP300—alcohol dependence	1.26e-05	0.000105	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT1—alcohol dependence	1.24e-05	0.000104	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT1—alcohol dependence	1.24e-05	0.000104	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT1—alcohol dependence	1.23e-05	0.000103	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT1—alcohol dependence	1.23e-05	0.000103	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MAOA—alcohol dependence	1.21e-05	0.000101	CbGpPWpGaD
Gefitinib—EGFR—Disease—EP300—alcohol dependence	1.2e-05	0.000101	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MAOA—alcohol dependence	1.18e-05	9.84e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.17e-05	9.78e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MAOA—alcohol dependence	1.11e-05	9.28e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	1.1e-05	9.22e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOA—alcohol dependence	1.1e-05	9.2e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	1.07e-05	8.92e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—alcohol dependence	1.02e-05	8.49e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—alcohol dependence	9.61e-06	8.02e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—EP300—alcohol dependence	9.42e-06	7.86e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT2—alcohol dependence	9.39e-06	7.84e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	8.83e-06	7.37e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—alcohol dependence	8.76e-06	7.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—EP300—alcohol dependence	8.44e-06	7.04e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT1—alcohol dependence	8.11e-06	6.77e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT1—alcohol dependence	8.11e-06	6.77e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—alcohol dependence	7.86e-06	6.57e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—alcohol dependence	7.68e-06	6.41e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOA—alcohol dependence	7.26e-06	6.06e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—alcohol dependence	7.23e-06	6.04e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—alcohol dependence	7.17e-06	5.99e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—EP300—alcohol dependence	6.75e-06	5.63e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—EP300—alcohol dependence	6.38e-06	5.32e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—EP300—alcohol dependence	5.81e-06	4.85e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—EP300—alcohol dependence	5.22e-06	4.36e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—EP300—alcohol dependence	5.09e-06	4.25e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—EP300—alcohol dependence	4.8e-06	4.01e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—EP300—alcohol dependence	4.76e-06	3.97e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—alcohol dependence	4.73e-06	3.95e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—EP300—alcohol dependence	3.14e-06	2.62e-05	CbGpPWpGaD
